Skip to Content

Healius Ltd

HLS: XASX (AUS)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
A$6.00FmnpYswzthz

Healius Appears Undervalued With Cost Base and Balance Sheet Reset

Business Strategy and Outlook

In 2018, the former Primary Healthcare rebranded itself as Healius to signify the strategic turnaround underway. Healius is looking to new sources of strategic growth as well as dealing with prior underinvestment in infrastructure. There is much to fix in the business and we anticipate it to take a few years before significant margin improvements are made in the base pathology and imaging businesses. Healius selling its medical centers and Montserrat day hospitals to focus on redirecting capital toward infrastructure upgrades and its diagnostic businesses is viewed as a positive strategic step.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of HLS so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center